Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis (Q38128967)

29 August 2017

Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis (English)

1 reference

29 August 2017

0 references

hepatic encephalopathy

1 reference

Takumi Kawaguchi

1

1 reference

29 August 2017

Eitaro Taniguchi

series ordinal

2

1 reference

29 August 2017

Michio Sata

series ordinal

3

1 reference

29 August 2017

language of work or name

1 reference

14 August 2013

1 reference

Nutrition in Clinical Practice

29 August 2017

1 reference

29 August 2017

28

1 reference

29 August 2017

5

1 reference

29 August 2017

580-588

1 reference

Branched-chain amino acids as pharmacological nutrients in chronic liver disease

29 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids in liver disease: new aspects of long known phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

New therapeutic strategy for amino acid medicine: notable functions of branched chain amino acids as biological regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Purification and properties of branched-chain alpha-keto acid dehydrogenase phosphatase from bovine kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Three targets of branched-chain amino acid supplementation in the treatment of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Regulation of protein synthesis by branched-chain amino acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Regulation of protein synthesis by branched-chain amino acids in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Hypothalamic mTOR signaling regulates food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Hypothalamic leucine metabolism regulates liver glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Leucine is a direct-acting nutrient signal that regulates protein synthesis in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Role of branched-chain amino acids in management of cirrhosis and hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Alterations in expression of genes coding for proteins of the neurovascular unit in ischemic liver failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Motor vehicle accidents: how should cirrhotic patients be managed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Lipid profile is associated with the incidence of cognitive dysfunction in viral cirrhotic patients: A data-mining analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Marked depression of brain cholecystokinin and vasoactive intestinal polypeptide levels in Eck fistula dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Reduced somatostatin-like immunoreactivity in the brain of dogs with an Eck fistula.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nutrition in Hepatic Encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids in the treatment of chronic hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Ammonia metabolism, the brain and fatigue; revisiting the link.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Relation between glutamine, branched-chain amino acids, and protein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Ammonia-lowering strategies for the treatment of hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Alterations of blood brain barrier function in hyperammonemia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Clinical trial: oral zinc in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nitrogen metabolism in liver: structural and functional organization and physiological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched chain amino acids supplemented with L-acetylcarnitine versus BCAA treatment in hepatic coma: a randomized and controlled double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

The pathogenesis, complications and therapeutic strategy for hepatitis C virus-associated insulin resistance in the era of anti-viral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Localization of polypyrimidine-tract-binding protein is involved in the regulation of albumin synthesis by branched-chain amino acids in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Usefulness of granular BCAA after hepatectomy for liver cancer complicated with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Clinical comparison of branched-chain amino acid (l-Leucine, l-Isoleucine, l-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Posttranscriptional regulation of albumin gene expression by branched-chain amino acids in rats with acute liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids suppress insulin-resistance-based hepatocarcinogenesis in obese diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Attenuation of insulin-resistance-based hepatocarcinogenesis and angiogenesis by combined treatment with branched-chain amino acids and angiotensin-converting enzyme inhibitor in obese diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Possible role of visfatin in hepatoma progression and the effects of branched-chain amino acids on visfatin-induced proliferation in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids prevent insulin-induced hepatic tumor cell proliferation by inducing apoptosis through mTORC1 and mTORC2-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

The effect of a late evening snack in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

The effect of supplementation with branched-chain amino acids in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effects of a late evening snack combined with alpha-glucosidase inhibitor on liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acids and pigment epithelium-derived factor: novel therapeutic agents for hepatitis c virus-associated insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Potential role of branched-chain amino acids in glucose metabolism through the accelerated induction of the glucose-sensing apparatus in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Restoration of innate host defense responses by oral supplementation of branched-chain amino acids in decompensated cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Heating improves poor compliance with branched chain amino acid-rich supplementation in patients with liver cirrhosis: A before-after pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Significance of branched chain amino acids as possible stimulators of hepatocyte growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Branched-chain amino acid deficiency stabilizes insulin-induced vascular endothelial growth factor mRNA in hepatocellular carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Treatment with L-valine ameliorates liver fibrosis and restores thrombopoiesis in rats exposed to carbon tetrachloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effect of branched-chain amino acid supplementation on the oxidized/reduced state of plasma albumin in rats with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Malnutrition impairs interferon signaling through mTOR and FoxO pathways in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Valine, a branched-chain amino Acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

BCAA-enriched snack improves nutritional state of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Effect of an oral branched chain amino acid-enriched snack in cirrhotic patients with sleep disturbance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

The efficacy of nocturnal administration of branched-chain amino acid granules to improve quality of life in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Nutritional treatment of chronic liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0884533613496432

21 January 2018

Identifiers

DOI

10.1177/0884533613496432

1 reference

29 August 2017

1 reference